Incorporation of additional QC during subject sample analysis. [Bioanalytics]

posted by shreyas goswami  – India, 2024-03-12 10:22 (205 d 10:40 ago) – Posting: # 23902
Views: 2,192

Dear Members,

Seeking for better clarity ;-)

As stated in RDC27/2012 (ANVISA) "at least two QCs are within the range of measured concentrations." unlike other regulatory agencies where it is stated " At least two QCs should be below AVG Cmax".

How it should be evaluated during subject sample analysis for ANVISA submission studies?

Can we set pre defined criteria like....67% of total periods meet above mentioned criteria or it should be on the basis of average Cmax? :confused:

Kindly share your practice and inputs.

Regards,
Shreyas Goswami.

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,655 registered users;
84 visitors (0 registered, 84 guests [including 11 identified bots]).
Forum time: 22:02 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5